Age-related miRNAs dysregulation and abnormal BACE1 expression following Pb exposure in adolescent mice

Numbers of emerging evidence suggest that lead (Pb) exposure contributes to cognitive decline and might also increase the risk of Alzheimer's disease (AD) dementia in the elderly by increasing the beta-amyloid burden. Here, we aimed to characterize the effects of Pb on the post-transcriptional regulators, microRNAs (miRNAs), which may participate in AD pathogenesis. At first, early chronic Pb exposure on neuronal miRNAs expression with increasing aging was profiled to elucidate the association of three selected miRNAs with beta-site APP-cleaving enzyme 1(BACE1), a rate-limiting enzyme for beta-amyloid (A beta) production. Next, we verified changes in BACE1 were observed by regulating miRNAs expression in vitro. While Pb promoted BACE1 levels, BACE1 levels were reduced in SH-SY5Y cells with miR-124-3p mimic, suggesting for the first time that miR-124-3p/BACE1 pathway modulation is critically involved in Pb-induced AD-like amyloidogenic processing. Findings from this study could provide new insight into the molecular mechanisms of Pb-associated neurodegenerative pathogenesis from an epigenetic perspective.

Automated summary

Emerging evidence suggests that lead (Pb) exposure contributes to cognitive decline and increases the risk of Alzheimer's disease (AD) dementia. This study investigates the effects of Pb on microRNAs (miRNAs), which play a role in AD pathogenesis. The findings suggest that miR-124-3p/BACE1 pathway modulation is critically involved in Pb-induced AD-like amyloidogenic processing.